TETRAPHASE PHARMACEUTICALS I
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for TETRAPHASE PHARMACEUTICALS I COM, CUSIP 88165n105.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for TETRAPHASE PHARMACEUTICALS I COM, CUSIP 88165n105.